GGrantIndex
← Leaderboards

Mehmet Kesimer

Univ Of North Carolina Chapel Hill

$11,256,253
Attributed
$12,710,925
Total exposure
8
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.7M · FY201023
$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23

Funding mix

By agency

NIH$12,710,925 · 8

By mechanism

R01$6,146,404 · 3
P01$3,619,319 · 4
P50$2,945,202 · 1

Top collaborators

Most similar at Univ Of North Carolina Chapel Hill

Same institution · by research overlap

Others in their field

Top investigators on “Mucins

Research focus

MucinsMucous Body SubstancePropertyProteinsBiochemicalRheologyStructureLungWestern BlottingMass Spectrum AnalysisMeasurementBaseCystic FibrosisEpithelialCoughingInfectionInflammationViscoelasticityMicrospheresSolidMuc5b GeneMuc5ac GeneSurfaceCone

Grant awards (32)

Core B: Mucus/Mucin Analytics Core$268,314
P01 · FY2023 · HL · contact PI
Core B: Mucus/Mucin Analytics Core$268,314
P01 · FY2022 · HL · contact PI
The effect of Inhaled Nicotine on Pulmonary Surfaces$557,231
R01 · FY2021 · HL
Core B: Analytics for Mucolytics Core$286,551
P01 · FY2021 · HL · contact PI
The effect of Inhaled Nicotine on Pulmonary Surfaces$465,175
R01 · FY2020 · HL
The effect of Inhaled Nicotine on Pulmonary Surfaces$456,000
R01 · FY2020 · HL
Core B: Analytics for Mucolytics Core$321,943
P01 · FY2020 · HL · contact PI
The effect of Inhaled Nicotine on Pulmonary Surfaces$62,939
R01 · FY2020 · HL
The effect of Inhaled Nicotine on Pulmonary Surfaces$456,000
R01 · FY2019 · HL
Core B: Analytics for Mucolytics Core$244,443
P01 · FY2019 · HL · contact PI
The effect of Inhaled Nicotine on Pulmonary Surfaces$456,000
R01 · FY2018 · HL
Core B: Analytics for Mucolytics Core$321,943
P01 · FY2018 · HL · contact PI
Project 1: The Effects of New and Emerging Tobacco Products on Lung Hyd$574,366
P50 · FY2017 · HL · contact PI
The effect of Inhaled Nicotine on Pulmonary Surfaces$456,000
R01 · FY2017 · HL
Core B: Analytics for Mucolytics Core$330,458
P01 · FY2017 · HL · contact PI
Project 1: The Effects of New and Emerging Tobacco Products on Lung Hyd$572,709
P50 · FY2016 · HL · contact PI
Mucus Core$404,915
P01 · FY2016 · HL · contact PI
Project 1: The Effects of New and Emerging Tobacco Products on Lung Hyd$572,709
P50 · FY2015 · HL · contact PI
Mucus Core$400,460
P01 · FY2015 · HL · contact PI
Project 1: The Effects of New and Emerging Tobacco Products on Lung Hyd$572,709
P50 · FY2014 · HL · contact PI
Mucus Core$397,690
P01 · FY2014 · HL · contact PI
Airway mucus/mucin composition and proteome in COPD: A SPIROMICS ancillary study$362,600
R01 · FY2014 · HL · contact PI
The role of mucin-protein interactions in the innate defense of the lung$358,974
R01 · FY2014 · HL · contact PI
Project 1: The Effects of New and Emerging Tobacco Products on Lung Hyd$652,709
P50 · FY2013 · HL · contact PI
Mucus Core$374,288
P01 · FY2013 · HL · contact PI
Airway mucus/mucin composition and proteome in COPD: A SPIROMICS ancillary study$352,240
R01 · FY2013 · HL · contact PI
The role of mucin-protein interactions in the innate defense of the lung$348,718
R01 · FY2013 · HL · contact PI
Airway mucus/mucin composition and proteome in COPD: A SPIROMICS ancillary study$370,000
R01 · FY2012 · HL · contact PI
The role of mucin-protein interactions in the innate defense of the lung$366,300
R01 · FY2012 · HL · contact PI
The role of mucin-protein interactions in the innate defense of the lung$370,000
R01 · FY2011 · HL · contact PI
Airway mucus/mucin composition and proteome in COPD: A SPIROMICS ancillary study$338,227
R01 · FY2011 · HL · contact PI
The role of mucin-protein interactions in the innate defense of the lung$370,000
R01 · FY2010 · HL · contact PI